BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19082436)

  • 1. Surfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? (Review).
    Vaid M; Floros J
    Oncol Rep; 2009 Jan; 21(1):3-11. PubMed ID: 19082436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular cytopathology of lung cancer--prevalence of genetic alterations and their role in the development of molecular biomarkers].
    Grote HJ; Schmiemann V; Böcking A
    Verh Dtsch Ges Pathol; 2003; 87():142-9. PubMed ID: 16888906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation profile and expression of surfactant protein A2 gene in lung cancer.
    Grageda M; Silveyra P; Thomas NJ; DiAngelo SL; Floros J
    Exp Lung Res; 2015 Mar; 41(2):93-102. PubMed ID: 25514367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aberrant promoter methylation of tumor suppressor genes in serum from lung cancer patients: frequency and correlation with clinicopathological characteristics].
    Zemaitis M; Rieger N; Fischer JR; Sakalauskas R; Malakauskas K; Lahm H
    Medicina (Kaunas); 2005; 41(2):123-31. PubMed ID: 15758578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of function of p16 gene and prognosis of pulmonary adenocarcinoma.
    Tanaka R; Wang D; Morishita Y; Inadome Y; Minami Y; Iijima T; Fukai S; Goya T; Noguchi M
    Cancer; 2005 Feb; 103(3):608-15. PubMed ID: 15612080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.
    Poursoltan P; Currey N; Pangon L; van Kralingen C; Selinger CI; Mahar A; Cooper WA; Kennedy CW; McCaughan BC; Trent R; Kohonen-Corish MR
    Lung Cancer; 2012 Aug; 77(2):272-6. PubMed ID: 22542170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
    Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
    Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of insulin and dexamethasone on pulmonary surfactant-associated genes and proteins in A549 and H441 cells and lung tissue.
    Rucka Z; Vanhara P; Koutna I; Tesarova L; Potesilova M; Stejskal S; Simara P; Dolezel J; Zvonicek V; Coufal O; Capov I
    Int J Mol Med; 2013 Jul; 32(1):211-8. PubMed ID: 23620014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of P16 Gene Methylation in Lung Cancer.
    Li Y; Zhang T; Zhang H; Wang X; Liu X; Huang Q; Li L
    Adv Exp Med Biol; 2020; 1255():133-142. PubMed ID: 32949396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of aberrant Wnt7a promoter methylation in human non-small cell lung cancer in Koreans.
    Kim TH; Moon JY; Kim SH; Paik SS; Yoon HJ; Shin DH; Park SS; Sohn JW
    J Korean Med Sci; 2015 Feb; 30(2):155-61. PubMed ID: 25653486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
    Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer.
    Fujiwara K; Fujimoto N; Tabata M; Nishii K; Matsuo K; Hotta K; Kozuki T; Aoe M; Kiura K; Ueoka H; Tanimoto M
    Clin Cancer Res; 2005 Feb; 11(3):1219-25. PubMed ID: 15709192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients.
    Ponomaryova AA; Rykova EY; Cherdyntseva NV; Skvortsova TE; Dobrodeev AY; Zav'yalov AA; Bryzgalov LO; Tuzikov SA; Vlassov VV; Laktionov PP
    Lung Cancer; 2013 Sep; 81(3):397-403. PubMed ID: 23806794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation analysis: a powerful new tool for lung cancer diagnosis.
    Tsou JA; Hagen JA; Carpenter CL; Laird-Offringa IA
    Oncogene; 2002 Aug; 21(35):5450-61. PubMed ID: 12154407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
    Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
    Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
    Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
    Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA methylation markers of surfactant proteins in lung cancer.
    Lin Z; Thomas NJ; Bibikova M; Seifart C; Wang Y; Guo X; Wang G; Vollmer E; Goldmann T; Garcia EW; Zhou L; Fan JB; Floros J
    Int J Oncol; 2007 Jul; 31(1):181-91. PubMed ID: 17549420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.